KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - Net
Ratios

Organon (OGN) EBIAT (2020 - 2025)

Organon has reported EBIAT over the past 6 years, most recently at -$205.0 million for Q4 2025.

  • Quarterly results put EBIAT at -$205.0 million for Q4 2025, down 288.07% from a year ago — trailing twelve months through Dec 2025 was $187.0 million (down 78.36% YoY), and the annual figure for FY2025 was $187.0 million, down 78.36%.
  • EBIAT for Q4 2025 was -$205.0 million at Organon, down from $160.0 million in the prior quarter.
  • Over the last five years, EBIAT for OGN hit a ceiling of $546.0 million in Q4 2023 and a floor of -$205.0 million in Q4 2025.
  • Median EBIAT over the past 5 years was $201.5 million (2021), compared with a mean of $217.1 million.
  • Biggest five-year swings in EBIAT: soared 518.97% in 2024 and later crashed 288.07% in 2025.
  • Organon's EBIAT stood at $202.0 million in 2021, then tumbled by 46.53% to $108.0 million in 2022, then skyrocketed by 405.56% to $546.0 million in 2023, then plummeted by 80.04% to $109.0 million in 2024, then crashed by 288.07% to -$205.0 million in 2025.
  • The last three reported values for EBIAT were -$205.0 million (Q4 2025), $160.0 million (Q3 2025), and $145.0 million (Q2 2025) per Business Quant data.